Literature DB >> 19497744

Identification of a beta3-peptide HIV fusion inhibitor with improved potency in live cells.

Arjel D Bautista1, Olen M Stephens, Ligong Wang, Robert A Domaoal, Karen S Anderson, Alanna Schepartz.   

Abstract

We recently reported a beta(3)-decapeptide, betaWWI-1, that binds a validated gp41 model in vitro and inhibits gp41-mediated fusion in cell culture. Here we report six analogs of betaWWI-1 containing a variety of non-natural side chains in place of the central tryptophan of the WWI-epitope. These analogs were compared on the basis of both gp41 affinity in vitro and fusion inibition in live, HIV-infected cells. One new beta(3)-peptide, betaWXI-a, offers a significantly improved CC(50)/EC(50) ratio in the live cell assay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19497744      PMCID: PMC2737262          DOI: 10.1016/j.bmcl.2009.05.032

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  33 in total

1.  De novo design of a monomeric helical beta-peptide stabilized by electrostatic interactions.

Authors:  R P Cheng; W F DeGrado
Journal:  J Am Chem Soc       Date:  2001-05-30       Impact factor: 15.419

2.  Efficient synthesis of a beta-peptide combinatorial library with microwave irradiation.

Authors:  Justin K Murray; Bilal Farooqi; Jack D Sadowsky; Mark Scalf; Wesley A Freund; Lloyd M Smith; Jiandong Chen; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2005-09-28       Impact factor: 15.419

3.  Pharmacokinetic investigation of a 14C-labelled beta 3/alpha tetrapeptide in rats.

Authors:  Hansjörg Wiegand; Bernard Wirz; Alain Schweitzer; Gerhard Gross; Maria I Rodriguez Perez; Hendrik Andres; Thierry Kimmerlin; Magnus Rueping; Dieter Seebach
Journal:  Chem Biodivers       Date:  2004-11       Impact factor: 2.408

4.  Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.

Authors:  Gary Frey; Sophia Rits-Volloch; X-Q Zhang; Robert T Schooley; Bing Chen; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

Review 5.  Sophistication of foldamer form and function in vitro and in vivo.

Authors:  Arjel D Bautista; Cody J Craig; Elizabeth A Harker; Alanna Schepartz
Journal:  Curr Opin Chem Biol       Date:  2007-11-07       Impact factor: 8.822

6.  Potent D-peptide inhibitors of HIV-1 entry.

Authors:  Brett D Welch; Andrew P VanDemark; Annie Heroux; Christopher P Hill; Michael S Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

7.  Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.

Authors:  John J Dwyer; Karen L Wilson; Donna K Davison; Stephanie A Freel; Jennifer E Seedorff; Stephen A Wring; Nicolai A Tvermoes; Thomas J Matthews; Michael L Greenberg; Mary K Delmedico
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-19       Impact factor: 11.205

8.  Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor.

Authors:  Yuxian He; Yonghong Xiao; Haifeng Song; Qing Liang; Dan Ju; Xin Chen; Hong Lu; Weiguo Jing; Shibo Jiang; Linqi Zhang
Journal:  J Biol Chem       Date:  2008-02-26       Impact factor: 5.157

9.  Inhibiting HIV fusion with a beta-peptide foldamer.

Authors:  Olen M Stephens; Sunghwan Kim; Brett D Welch; Michael E Hodsdon; Michael S Kay; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2005-09-28       Impact factor: 15.419

10.  Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.

Authors:  B S Jin; J R Ryu; K Ahn; Y G Yu
Journal:  AIDS Res Hum Retroviruses       Date:  2000-11-20       Impact factor: 2.205

View more
  12 in total

1.  Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic library.

Authors:  Landon R Whitby; Kristopher E Boyle; Lifeng Cai; Xiaoqian Yu; Miriam Gochin; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2012-03-03       Impact factor: 2.823

2.  Rotamer Libraries for the High-Resolution Design of β-Amino Acid Foldamers.

Authors:  Andrew M Watkins; Timothy W Craven; P Douglas Renfrew; Paramjit S Arora; Richard Bonneau
Journal:  Structure       Date:  2017-10-12       Impact factor: 5.006

3.  Bridged beta(3)-peptide inhibitors of p53-hDM2 complexation: correlation between affinity and cell permeability.

Authors:  Arjel D Bautista; Jacob S Appelbaum; Cody J Craig; Julien Michel; Alanna Schepartz
Journal:  J Am Chem Soc       Date:  2010-03-10       Impact factor: 15.419

4.  Helix formation in preorganized beta/gamma-peptide foldamers: hydrogen-bond analogy to the alpha-helix without alpha-amino acid residues.

Authors:  Li Guo; Aaron M Almeida; Weicheng Zhang; Andrew G Reidenbach; Soo Hyuk Choi; Ilia A Guzei; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2010-06-16       Impact factor: 15.419

5.  Geared Toward Applications: A Perspective on Functional Sequence-Controlled Polymers.

Authors:  Cangjie Yang; Kevin B Wu; Yu Deng; Jingsong Yuan; Jia Niu
Journal:  ACS Macro Lett       Date:  2021-01-20       Impact factor: 6.903

Review 6.  Protease-resistant peptide design-empowering nature's fragile warriors against HIV.

Authors:  Matthew T Weinstock; J Nicholas Francis; Joseph S Redman; Michael S Kay
Journal:  Biopolymers       Date:  2012       Impact factor: 2.505

7.  A β-peptide agonist of the GLP-1 receptor, a class B GPCR.

Authors:  Elizabeth V Denton; Cody J Craig; Rebecca L Pongratz; Jacob S Appelbaum; Amy E Doerner; Arjun Narayanan; Gerald I Shulman; Gary W Cline; Alanna Schepartz
Journal:  Org Lett       Date:  2013-10-02       Impact factor: 6.005

8.  Sulfono-γ-AA modified peptides that inhibit HIV-1 fusion.

Authors:  Olapeju Bolarinwa; Meng Zhang; Erin Mulry; Min Lu; Jianfeng Cai
Journal:  Org Biomol Chem       Date:  2018-10-31       Impact factor: 3.876

Review 9.  Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.

Authors:  Marta Pelay-Gimeno; Adrian Glas; Oliver Koch; Tom N Grossmann
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-26       Impact factor: 15.336

10.  A foldamer-dendrimer conjugate neutralizes synaptotoxic β-amyloid oligomers.

Authors:  Lívia Fülöp; István M Mándity; Gábor Juhász; Viktor Szegedi; Anasztázia Hetényi; Edit Wéber; Zsolt Bozsó; Dóra Simon; Mária Benkő; Zoltán Király; Tamás A Martinek
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.